NCT00285025View on ClinicalTrials.gov

Study of the Effect of SR57667B in Patients With Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

September 30, 2005

Conditions
Alzheimer Disease
Interventions
DRUG

SR57667B

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY